Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,241Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Lunesta

PharmaCompass

01

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 125

2019 Revenue in Millions : 117

Growth (%) : 7

blank

02

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : Sleep

Currency : USD

2021 Revenue in Millions : 79

2020 Revenue in Millions : 120

Growth (%) : -30

blank

03

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : Sleep

Currency : USD

2022 Revenue in Millions : 8

2021 Revenue in Millions : 79

Growth (%) : -89

blank

04

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : Sleep Disorders

Currency : USD

2016 Revenue in Millions : 2

2015 Revenue in Millions : 50

Growth (%) : -96

blank

05

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 95

2016 Revenue in Millions : 72

Growth (%) : 32

blank

06

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 99

2017 Revenue in Millions : 89

Growth (%) : 11%

blank

07

Brand Name : Lunesta

Eszopiclone

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Lunesta

arrow
Fi Europe 2024
Not Confirmed

Eszopiclone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 113

2018 Revenue in Millions : 102

Growth (%) : 11

blank